Skip to NavigationSkip to content

News

0
Over half of all anti-vaccine ads on Facebook stem from just two advertisers
A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both of whom are...
0
Shionogi gains US approval in complicated urinary tract infections with Fetroja
Shionogi’s antibacterial therapy Fetroja (cefiderocol) has secured approval in the US for the treatment of complicated urinary tract infections (...
0
Label expansion of Amarin's Vascepa has unanimous backing of FDA advisory panel
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted in favour of expanding the existing approval of Irish firm Amarin...
0
Top Ten most popular articles on Pharmafile.com this week
NHS to use its first cannabis-based therapies following NICE approval, while Vertex's cystic fibrosis portfolio to be made available in Northern...
>> More News Stories

Features

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

“At every stage of my career, whether it was forwards or sideways, I’ve tried to learn something and bring something to the role...

>> More Features
>> More News Stories